Asymmetric dimethylation of H4R3 by PRMT1 at the ZEB1 promoter is also described as promoting the acquisition of stem cell characteristics in BC cells and may contribute to the PRMT1-dependent inhibition of senescence in BC cells [23]. Here, PRMT1 is linked to breast cancer.